Aaron Cooper

Company: Arsenal Bio

Job title: Vice President, Early Discovery

Seminars:

Programming T-Cells with Synthetic Immunology to Overcome Solid Tumor Barriers 3:30 pm

Achieving efficacy in solid tumor cell therapy requires addressing challenges of insufficient specificity and potency of conventional designs ArsenalBio has developed technologies, manufacturing, and regulatory know-how to make T-cell products with large, multi-functional transgenes to address these challenges We are advancing a pipeline of therapies for solid tumor indicationsRead more

day: Post-Conference Solid Tumor Focus Day